Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021

Patrick Wg Mallon; Mary Horgan; Conor G McAloon; Peter D Lunn; Julian Little; Andrew Beck; Alexandria Bennett; Nicole Shaver; Aileen Conway; Rhea O'Regan; Barbara Whelan; Rapid Testing Expert Advisory Group, Ireland; Members of the Rapid Testing Expert Advisory Group

doi:10.2807/1560-7917.ES.2022.27.3.2101202

Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021

Euro Surveill. 2022 Jan;27(3):2101202. doi: 10.2807/1560-7917.ES.2022.27.3.2101202.

Collaborators

Mary Horgan, Jeff Connell, Pete Lunn, Patrick Mallon, Kingston Hg Mills, Patrick O'Mahony, Anna-Rose Prior, Breda Smyth

Affiliations

¹ Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Dublin, Ireland.
² School of Medicine, University College Cork and Cork University Hospital, Cork, Ireland.
³ School of Veterinary Medicine, University College Dublin, Belfield, Dublin, Ireland.
⁴ Behavioural Research Unit, Economic and Social Research Institute, Dublin, Ireland.
⁵ Knowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
⁶ Evidence Synthesis Ireland, School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland.
⁷ The members of the RTEAG who were involved in writing this paper are listed under Investigators.

PMID: 35057900
PMCID: PMC8804664
DOI: 10.2807/1560-7917.ES.2022.27.3.2101202

Abstract

We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation measure to reduce transmission of SARS-CoV-2. The tool aims to stratify, in real time, the overall risk of SARS-CoV-2 transmission associated with common activities and events, and this can be matched to an appropriate Ag-RDT testing protocol.

Keywords: Ag-RDT; Covid-19; Ireland; RADT; SARS-CoV-2; rapid antigen detection test; risk assessment.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antigens, Viral
COVID-19*
Humans
Ireland
Risk Assessment
SARS-CoV-2*
Sensitivity and Specificity

Substances

Antigens, Viral